STAT3 and breast cancer: Whereas Y705 phosphorylation has affected all pro-metastatic functions of TME-stimulated HR+/HER2− breast cancer cells, the complete absence of STAT3—with its S727 phosphorylation site and other regulatory domains [61]—had no influence on tumor-promoting activities, of any kind.